FLT1 and Duchenne muscular dystrophy: To translate our genetic results into therapeutic approaches for DMD model mice, we utilized a previously reported anti-FLT1 hexapeptide (Gly-Asn-Gln-Trp-Phe-Ile or GNQWFI) that inhibits VEGF-binding to FLT1.